Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines <it>in vitro </it>and in <it>scid </it>mice
<p>Abstract</p> <p>Background</p> <p>Despite exciting new targeted therapeutics against non-Hodgkin's lymphoma (NHL), chemotherapy remains a cornerstone of therapy. While purine nucleoside analogs have significant activity in low grade NHL, the pyrimidine nucleoside analog gemcitabine has been less...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2005-08-01
|
| Sarja: | BMC Cancer |
| Linkit: | http://www.biomedcentral.com/1471-2407/5/103 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|